RegulyzeBilberry
Vaccinium myrtillus · Extract
Bilberry (Vaccinium myrtillus) is a nutraceutical permitted for use in nutraceuticals and health supplements under India's FSSAI framework, with a permitted limit of 50-600 mg/day max. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | 50-600 mg/day max | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Bilberry
Bilberry is tracked in the Regulyze Ingredient Intelligence database as a nutraceutical (Vaccinium myrtillus). The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Bilberry permitted in nutraceuticals under FSSAI (India)?
Bilberry (Vaccinium myrtillus) (listed in the regulation as “Vaccinium myrtillus extract”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Bilberry?
The permitted level recorded for Bilberry is 50-600 mg/day max. Limits can vary by product type and market — confirm against the current regulation.
What product category does Bilberry belong to?
Bilberry is classified under: Nutraceuticals, Botanicals.
What is the botanical (scientific) name of Bilberry?
Bilberry corresponds to Vaccinium myrtillus, with the extract used in nutraceutical preparations.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.